MedPath

TRUXIMA

TRUXIMA

Approved
DIN Number

02478390

Drug Class

Human

Market Date

Dec 11, 2019

Company
HC

Celltrion Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02478390
AIG Number0140241001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FA01 RITUXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

RITUXIMABActive
Strength: 500 MG / 50 ML
Monograph: RITUXIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.